Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_provenance.
- NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_assertion description "[Mitchell B. Balter Award. Human leukocyte antigen-A1 predicts a good therapeutic response to clozapine with a low risk of agranulocytosis in patients with schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_provenance.
- NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_assertion evidence source_evidence_literature NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_provenance.
- NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_assertion SIO_000772 11199946 NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_provenance.
- NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_assertion wasDerivedFrom befree-20140225 NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_provenance.
- NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_assertion wasGeneratedBy ECO_0000203 NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP795077.RAYKlH_W-jnE7l6OTB37r8s3wFpJeJh5f8l1ipN7Y-ASk130_provenance.